"Levamisole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
Below are MeSH descriptors whose meaning is more general than "Levamisole".
Below are MeSH descriptors whose meaning is more specific than "Levamisole".
This graph shows the total number of publications written about "Levamisole" by people in this website by year, and whether "Levamisole" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Levamisole" by people in Profiles.
Probing enzymatic activity inside single cells. Anal Chem. 2013 Nov 05; 85(21):10126-33.
The cocaine trail: levamisole-induced leukocytoclastic vasculitis in a cocaine user. Subst Abus. 2013; 34(1):75-7.
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J Natl Cancer Inst. 2011 Oct 19; 103(20):1498-506.
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol. 1979 Apr; 5(4):338-42.
Suppressor cell function in multiple sclerosis. Ann Immunol (Paris). 1978 Feb-Mar; 129(2-3):159-70.